NCT01341132 Evaluation of Cirrhosis and Malignant Hepatic Lesions Using Novel MR Contrast Agents Status UNKNOWN Phase N/A
NCT01340105 Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency Ablation Status COMPLETED Phase NA
NCT01335074 Temsirolimus + Sorafenib in Advanced Hepatocellular Carcinoma (HCC) Status WITHDRAWN Phase PHASE1/PHASE2
NCT01334112 Study of Axitinib in Patients With Unresectable Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT01328223 Study of Combined Sorafenib With Radiotherapy in Patients With Advanced Hepatocellular Carcinoma Status UNKNOWN Phase N/A
NCT01322477 Contribution of F-18 Fluoro-Deoxy-Glucose PET/CT (Positron Emission Tomography) to the Assessment of HCC (Hepato-cellular Carcinoma) Treatment Efficiency Status UNKNOWN Phase N/A
NCT01320852 PET Scan as a Screening Tool for Liver Transplant in Patients With Hepatocellular Carcinoma (HCC) Status COMPLETED Phase NA
NCT01316679 An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423 Status COMPLETED Phase N/A
NCT01308645 Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Primary Hepatocellular Carcinoma (HCC) Status UNKNOWN Phase PHASE2
NCT01300143 Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT01290523 Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular Carcinoma Status TERMINATED Phase NA
NCT01287585 Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy Status COMPLETED Phase PHASE3
NCT01281683 Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy Status UNKNOWN Phase N/A
NCT01277653 Study of PIVKA-II and AFP Measurement in Surveillance Program for Early Detection of Hepatocellular Carcinoma Status UNKNOWN Phase N/A
NCT01273662 Axitinib as Second-line Treatment for Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT01271504 E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma Status COMPLETED Phase PHASE1/PHASE2